ネクセラファーマの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/09/22 | 1,849 | 1,879 | 1,790 | 1,809 | -72 | -3.8% | 2,269,700 |
| 2022/09/21 | 1,888 | 1,891 | 1,846 | 1,881 | -25 | -1.3% | 1,041,200 |
| 2022/09/20 | 1,940 | 1,950 | 1,843 | 1,906 | -33 | -1.7% | 1,788,500 |
| 2022/09/16 | 1,952 | 1,968 | 1,896 | 1,939 | +17 | +0.9% | 1,783,000 |
| 2022/09/15 | 1,926 | 1,954 | 1,910 | 1,922 | +19 | +1% | 1,197,800 |
| 2022/09/14 | 1,843 | 1,919 | 1,841 | 1,903 | +11 | +0.6% | 1,287,900 |
| 2022/09/13 | 1,846 | 1,920 | 1,840 | 1,892 | +44 | +2.4% | 1,543,400 |
| 2022/09/12 | 1,818 | 1,848 | 1,803 | 1,848 | +41 | +2.3% | 1,204,600 |
| 2022/09/09 | 1,707 | 1,816 | 1,696 | 1,807 | +108 | +6.4% | 1,951,400 |
| 2022/09/08 | 1,714 | 1,726 | 1,685 | 1,699 | +14 | +0.8% | 814,800 |
| 2022/09/07 | 1,714 | 1,726 | 1,675 | 1,685 | -30 | -1.7% | 915,800 |
| 2022/09/06 | 1,738 | 1,752 | 1,711 | 1,715 | -23 | -1.3% | 772,200 |
| 2022/09/05 | 1,708 | 1,745 | 1,694 | 1,738 | +25 | +1.5% | 963,400 |
| 2022/09/02 | 1,750 | 1,773 | 1,711 | 1,713 | -27 | -1.6% | 1,083,800 |
| 2022/09/01 | 1,737 | 1,757 | 1,724 | 1,740 | -6 | -0.3% | 686,500 |
| 2022/08/31 | 1,740 | 1,750 | 1,731 | 1,746 | +6 | +0.3% | 466,200 |
| 2022/08/30 | 1,730 | 1,740 | 1,703 | 1,740 | +26 | +1.5% | 830,300 |
| 2022/08/29 | 1,693 | 1,729 | 1,678 | 1,714 | -47 | -2.7% | 1,462,300 |
| 2022/08/26 | 1,742 | 1,795 | 1,738 | 1,761 | +19 | +1.1% | 1,316,800 |
| 2022/08/25 | 1,726 | 1,766 | 1,721 | 1,742 | +69 | +4.1% | 1,818,400 |
| 2022/08/24 | 1,728 | 1,736 | 1,673 | 1,673 | -62 | -3.6% | 1,106,500 |
| 2022/08/23 | 1,718 | 1,741 | 1,702 | 1,735 | -6 | -0.3% | 1,009,600 |
| 2022/08/22 | 1,696 | 1,754 | 1,677 | 1,741 | +27 | +1.6% | 1,832,800 |
| 2022/08/19 | 1,667 | 1,728 | 1,662 | 1,714 | +54 | +3.3% | 1,536,000 |
| 2022/08/18 | 1,632 | 1,665 | 1,625 | 1,660 | +4 | +0.2% | 989,700 |
| 2022/08/17 | 1,624 | 1,674 | 1,619 | 1,656 | +19 | +1.2% | 1,094,000 |
| 2022/08/16 | 1,590 | 1,638 | 1,585 | 1,637 | +35 | +2.2% | 1,313,500 |
| 2022/08/15 | 1,606 | 1,622 | 1,581 | 1,602 | -18 | -1.1% | 1,078,100 |
| 2022/08/12 | 1,624 | 1,654 | 1,566 | 1,620 | +36 | +2.3% | 2,000,000 |
| 2022/08/10 | 1,621 | 1,625 | 1,572 | 1,584 | -75 | -4.5% | 1,438,300 |
| 2022/08/09 | 1,654 | 1,672 | 1,625 | 1,659 | +37 | +2.3% | 1,411,500 |
| 2022/08/08 | 1,593 | 1,641 | 1,588 | 1,622 | +9 | +0.6% | 1,192,000 |
| 2022/08/05 | 1,640 | 1,703 | 1,596 | 1,613 | +29 | +1.8% | 3,376,500 |
| 2022/08/04 | 1,568 | 1,611 | 1,543 | 1,584 | +14 | +0.9% | 2,252,500 |
| 2022/08/03 | 1,522 | 1,608 | 1,477 | 1,570 | +70 | +4.7% | 3,476,800 |
| 2022/08/02 | 1,560 | 1,637 | 1,485 | 1,500 | +70 | +4.9% | 7,170,600 |
| 2022/08/01 | 1,432 | 1,455 | 1,414 | 1,430 | ±0 | ±0% | 1,356,800 |
| 2022/07/29 | 1,370 | 1,488 | 1,362 | 1,430 | +106 | +8% | 4,073,000 |
| 2022/07/28 | 1,358 | 1,359 | 1,298 | 1,324 | -37 | -2.7% | 940,900 |
| 2022/07/27 | 1,327 | 1,369 | 1,327 | 1,361 | +33 | +2.5% | 858,500 |
| 2022/07/26 | 1,347 | 1,360 | 1,312 | 1,328 | -4 | -0.3% | 1,073,600 |
| 2022/07/25 | 1,331 | 1,340 | 1,304 | 1,332 | +27 | +2.1% | 1,078,800 |
| 2022/07/22 | 1,289 | 1,306 | 1,272 | 1,305 | +40 | +3.2% | 591,000 |
| 2022/07/21 | 1,260 | 1,299 | 1,254 | 1,265 | +7 | +0.6% | 971,700 |
| 2022/07/20 | 1,246 | 1,261 | 1,232 | 1,258 | +33 | +2.7% | 544,500 |
| 2022/07/19 | 1,233 | 1,236 | 1,205 | 1,225 | -19 | -1.5% | 813,500 |
| 2022/07/15 | 1,260 | 1,266 | 1,238 | 1,244 | -35 | -2.7% | 696,500 |
| 2022/07/14 | 1,238 | 1,289 | 1,223 | 1,279 | +61 | +5% | 1,031,900 |
| 2022/07/13 | 1,211 | 1,230 | 1,205 | 1,218 | +7 | +0.6% | 473,100 |
| 2022/07/12 | 1,170 | 1,212 | 1,170 | 1,211 | +31 | +2.6% | 633,100 |
501～
550
件表示中 / 4944件
類似銘柄と比較する
現在ご覧いただいている「ネクセラファーマ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ネクセラファーマ | 125,100円 | +197.7% | - | 0.00% | 51.12倍 | 1.63倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
| ゼリア新薬 | 233,800円 | +9.6% | +17.5% | 1.97% | 13.21倍 | 1.29倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| 鳥居薬 | 393,500円 | +11.1% | +20.6% | 3.05% | 23.05倍 | 0.92倍 |
|
ＪＴ傘下。柱の抗ＨＩＶ薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
| 杏林製薬 | 153,100円 | +3.2% | +4.5% | 3.40% | 17.59倍 | 0.67倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
| 栄研化 | 246,000円 | +7.6% | +57.5% | 2.15% | 19.02倍 | 1.87倍 |
|
臨床検査薬大手。便潜血検査試薬（ＦＩＴ）はシェア７割。尿検査（ウロ）、遺伝子検査も育成 |
市場注目の銘柄
チャート関連のコラム
